ASLAN Pharmaceuticals Funding: $300M Raised, IPO (2018)
ASLAN Pharmaceuticals is based in Singapore. It has raised $300M in total funding. Latest round: IPO.
ASLAN Pharmaceuticals funding overview
ASLAN Pharmaceuticals is based in Singapore. ASLAN Pharmaceuticals has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in January 2018. The round record for ASLAN Pharmaceuticals runs through 2018; nothing later has been disclosed.
ASLAN Pharmaceuticals at a glance
Total raised
$300M
Latest round
IPO
Latest round date
January 2018
Headquarters
Singapore
Frequently asked about ASLAN Pharmaceuticals funding
How much has ASLAN Pharmaceuticals raised?
ASLAN Pharmaceuticals has raised $300M in total disclosed funding across the rounds on record.
Who has invested in ASLAN Pharmaceuticals?
No investors are named on the public record for ASLAN Pharmaceuticals yet.
What was the latest ASLAN Pharmaceuticals funding round?
The most recent disclosed round is an IPO, announced in January 2018.
Where is ASLAN Pharmaceuticals based?
ASLAN Pharmaceuticals is based in Singapore.
When did ASLAN Pharmaceuticals last raise?
The last disclosed ASLAN Pharmaceuticals round closed in January 2018 at IPO.
We update the ASLAN Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Singapore and their backers are listed below.
